rs6944808

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.1778-6682G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.698 in 152,112 control chromosomes in the GnomAD database, including 37,269 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.70 ( 37269 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0310

Publications

3 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.742 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.1778-6682G>A intron_variant Intron 11 of 23 ENST00000361727.8 NP_054860.1
CNTNAP2XM_017011950.3 linkc.1778-6682G>A intron_variant Intron 11 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.1778-6682G>A intron_variant Intron 11 of 23 1 NM_014141.6 ENSP00000354778.3
CNTNAP2ENST00000636870.1 linkn.1640-6682G>A intron_variant Intron 9 of 21 5
CNTNAP2ENST00000637825.1 linkn.1261-6682G>A intron_variant Intron 8 of 13 5
CNTNAP2ENST00000638117.1 linkn.1681-6682G>A intron_variant Intron 10 of 12 5

Frequencies

GnomAD3 genomes
AF:
0.698
AC:
106082
AN:
151994
Hom.:
37227
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.749
Gnomad AMI
AF:
0.717
Gnomad AMR
AF:
0.736
Gnomad ASJ
AF:
0.635
Gnomad EAS
AF:
0.624
Gnomad SAS
AF:
0.624
Gnomad FIN
AF:
0.618
Gnomad MID
AF:
0.646
Gnomad NFE
AF:
0.685
Gnomad OTH
AF:
0.692
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.698
AC:
106175
AN:
152112
Hom.:
37269
Cov.:
32
AF XY:
0.692
AC XY:
51485
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.749
AC:
31084
AN:
41494
American (AMR)
AF:
0.736
AC:
11255
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.635
AC:
2202
AN:
3470
East Asian (EAS)
AF:
0.624
AC:
3222
AN:
5166
South Asian (SAS)
AF:
0.625
AC:
3016
AN:
4826
European-Finnish (FIN)
AF:
0.618
AC:
6531
AN:
10574
Middle Eastern (MID)
AF:
0.634
AC:
185
AN:
292
European-Non Finnish (NFE)
AF:
0.685
AC:
46567
AN:
67982
Other (OTH)
AF:
0.691
AC:
1462
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1642
3284
4927
6569
8211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
822
1644
2466
3288
4110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.689
Hom.:
8956
Bravo
AF:
0.709
Asia WGS
AF:
0.638
AC:
2221
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.40
DANN
Benign
0.53
PhyloP100
-0.031
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6944808; hg19: chr7-147252548; API